There are a few natural alternatives available to increase GLP-1 levels without getting poked or prodded
Patients may also consult the FDA drug shortage database to review the current availability status for semaglutide
In a study of 1,961 non-diabetic, obese or overweight adults with weight-related medical problems, 30% of participants prescribed Wegovy lost 20% or more weight vs
Tai MH, Brown B, Taiji R, et al
NCT03600480), in which 96 participants with a BMI of 27.039.9 kg/m were randomised 3:1 to once-weekly subcutaneous cagrilintide (0.16, 0.30, 0.60, 1.2, 2.4 or 4.5 mg) or matched placebo, each in combination with once-weekly semaglutide 2.4 mg , across six sequential overlapping cohorts